Ioannidis M, Mahata S, van den Bogaart G
Peptides. 2022; 158:170893.
PMID: 36244579
PMC: 10760928.
DOI: 10.1016/j.peptides.2022.170893.
Brown M, Dainty S, Strudwick N, Mihai A, Watson J, Dendooven R
Mol Biol Cell. 2020; 31(23):2597-2629.
PMID: 32877278
PMC: 7851869.
DOI: 10.1091/mbc.E18-01-0013.
Yin C, Liu W, Liu Y, Wang L, Xiao Y
PLoS One. 2019; 14(4):e0214606.
PMID: 30990811
PMC: 6467375.
DOI: 10.1371/journal.pone.0214606.
Ward C, Lawrence M
Front Endocrinol (Lausanne). 2012; 2:76.
PMID: 22654826
PMC: 3356151.
DOI: 10.3389/fendo.2011.00076.
Strom T, Helderman J, Williams R
Immunogenetics. 2011; 7(1):51-6.
PMID: 21302056
DOI: 10.1007/BF01843987.
Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4.
Kim W, Khil L, Clark R, Bok S, Kim E, Lee S
Diabetologia. 2006; 49(10):2437-48.
PMID: 16896937
DOI: 10.1007/s00125-006-0373-6.
Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion.
Kisanuki K, Kishikawa H, Araki E, Shirotani T, Uehara M, Isami S
Diabetologia. 1995; 38(4):422-9.
PMID: 7796982
DOI: 10.1007/BF00410279.
Time-course of insulin degradation in perifused isolated rat adipose cells.
Huber C, Solomon S, Duckworth W
J Clin Invest. 1980; 65(2):461-8.
PMID: 7356690
PMC: 371384.
DOI: 10.1172/JCI109689.
Insulin receptors on isolated heart cells: effect of temperature and hydrolytic enzymes.
Eckel J, Offermann A, Reinauer H
Basic Res Cardiol. 1982; 77(3):323-32.
PMID: 7052057
DOI: 10.1007/BF01908047.
Affinity change of the adipocyte receptor fails to alter insulin-stimulated glucose transport.
McCaleb M, Donner D
Biochem J. 1982; 202(1):263-5.
PMID: 7044377
PMC: 1158101.
DOI: 10.1042/bj2020263.
Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity.
Ciaraldi T, Kolterman O, Olefsky J
J Clin Invest. 1981; 68(4):875-80.
PMID: 7026616
PMC: 370874.
DOI: 10.1172/jci110342.
Effects of prednisolone and dexamethasone in vivo and in vitro: studies of insulin binding, deoxyglucose uptake and glucose oxidation in rat adipocytes.
De Pirro R, Green A, Kao M, Olefsky J
Diabetologia. 1981; 21(2):149-53.
PMID: 7021286
DOI: 10.1007/BF00251283.
Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes.
Pedersen O, Hjollund E, Beck-Nielsen H, Lindskov H, Sonne O, GLIEMANN J
Diabetologia. 1981; 20(6):636-41.
PMID: 7021280
Hexose transport in human adipocytes: factors influencing the response to insulin and kinetics of methylglucose and glucose transport.
Pedersen O, GLIEMANN J
Diabetologia. 1981; 20(6):630-5.
PMID: 7021279
DOI: 10.1007/BF00257432.
Interaction of insulin with muscle receptors: specific binding of [125I]insulin by the plasma membrane of the rat skeletal muscle.
LEIBUSH B, Bondareva V
Neurosci Behav Physiol. 1980; 10(6):496-9.
PMID: 7012661
DOI: 10.1007/BF01195518.
Effect of a high glucose diet on insulin binding and insulin action in rat adipocytes. A longitudinal study.
Oka Y, Akanuma Y, Kasuga M, Kosaka K
Diabetologia. 1980; 19(5):468-74.
PMID: 7004966
DOI: 10.1007/BF00281828.
Effects of insulin incubation on insulin binding, glucose transport, and insulin degradation by isolated rat adipocytes. Evidence for hormone-induced desensitization at the receptor and postreceptor level.
Marshall S, Olefsky J
J Clin Invest. 1980; 66(4):763-72.
PMID: 6999035
PMC: 371651.
DOI: 10.1172/JCI109914.
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
Kolterman O, Insel J, Saekow M, Olefsky J
J Clin Invest. 1980; 65(6):1272-84.
PMID: 6997333
PMC: 371464.
DOI: 10.1172/JCI109790.
Insulin binding and hexose transport in rat adipocytes. Relation to cell size.
Foley J, Laursen A, Sonne O, GLIEMANN J
Diabetologia. 1980; 19(3):234-41.
PMID: 6997125
DOI: 10.1007/BF00275275.
Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.
King G, Kahn C, Rechler M, NISSLEY S
J Clin Invest. 1980; 66(1):130-40.
PMID: 6995478
PMC: 371514.
DOI: 10.1172/JCI109826.
